Glioma surgery with intraoperative mapping is increasingly becoming a key treatment and the philosophy of glioma resection guided by functional boundaries plays a key role in obtaining good surgical results in terms of extent of resection and survival rates. This has to be balanced against the risk of post-operative cognitive deterioration.
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I read with interest the paper published by Brennum and colleagues [1] on Acta Neurochirurgia in May this year. The authors have reported the results of glioma surgery with intraoperative mapping showing that 18% of the patients at 12 months has new or worsened minor or moderate deficits and only 10% has no deficits.
These results are rather significant and I do think that the authors must be commended for their honesty. The authors have shared their data regarding a heterogeneous population of patients and I do think that the results of this paper can be truly representative of what happens in most Units.
Nonetheless, there are a few points that in my opinion are not entirely clear. The authors state that adjuvant therapy is one of the factors analysed. However no breakdown of these results has been provided and I think that this would have been helpful, particularly if we consider that approximately 20% of the patients included in this study were affected by a grade III glioma.
Furthermore, in Table 3 , the authors have reported the reasons for terminating the procedure and specified this for 93% of their cases; it would be interesting to know what happened to the missing 7% of patients.
Noteworthy, the authors have collected data from several health professionals and must also be commended for this effort. However, in the methods, it is not clear how they have done this. In particular, it would have been helpful to know how they have balanced scenarios where the neurological outcomes have been rated differently by different health professionals.
Notwithstanding some minor criticisms related to the methods, I do think that this paper is a real pearl in that invites gliomas surgeons to analyse the surgical outcomes from a different perspective and to avoid underestimating the risk of post-operative cognitive deficits.
